Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M819Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-40.8EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)17.7Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M8,800,002ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with FBT

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

FBT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


FBT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Brown, ArthurDirector, Senior Officer 2016-11-08Buy25,000$0.2833142.86view
BACH, WENDYSenior Officer 2016-11-08Sell3,549$48.0693.67view
BACH, WENDYSenior Officer 2016-11-08Buy4,619$48.0893.59view
BACH, WENDYSenior Officer 2016-11-08Sell1,070$48.0693.67view
Miller, James MichaelSenior Officer 2016-11-08Buy5,000$4.32064.65view
Omni-Lite Industries Canada InIssuer 2016-11-08Buy2,300$1.655541.21view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-11-08Buy13,000$0.1371500view
Glazier, Patrick L.Director 2016-11-08Buy100,000$0.1466385.71view
Sutton, Brayden RobertDirector 2016-11-08Buy5,000$0.2833142.86view
Reilly, Robert BruceSenior Officer 2016-11-08Sell155,000$0.06155033.33view

Quarterly/Annual Reports about FBT:

    News about FBT:

    Articles On GuruFocus.com
    Low-Priced Retail Stocks Gurus Shopped for Ahead of Holiday Season Dec 02 2016 
    Barrick Repurchases $595 Million of Corporate Loan Dec 02 2016 
    23 Questions With Bakul Lalla Dec 02 2016 
    Qualcomm: Balance Sheet, Dividend Yield Make It Attractive Dec 02 2016 
    Apple: A Dividend Achiever in the Making Dec 02 2016 
    Neiman Marcus Debenture Bonds Yielding 8% Dec 02 2016 
    Competitor Performance Is Eating Nike’s Lunch Dec 02 2016 
    Smith & Wesson Reports Strong Quarter, but Stock Suffers Post Election Dec 02 2016 
    6 Things That May Surprise You About Building Wealth Dec 02 2016 
    Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals Dec 02 2016 

    More From Other Websites
    How Could Gilead Sciences Restore Its Growth? Dec 01 2016
    Why Neurocrine Biosciences May See Higher Losses in 2016 Dec 01 2016
    5 Reasons to Buy 5 Low P/E Biotech ETFs Nov 14 2016
    What Drove Regeneron’s 3Q16 Performance? Nov 09 2016
    Biotech ETFs Slumping on Q3 Results Nov 08 2016
    Strensiq: A Potential Driver for Alexion Nov 02 2016
    Once Beloved Momentum ETF Loses Its Momo Oct 27 2016
    Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech Oct 20 2016
    What Are the Drivers behind the Success of Soliris? Oct 20 2016
    Why Europe Is an Important Market for Vertex’s Orkambi Oct 19 2016
    How Regeneron Is Working to Maintain Eylea’s Dominance Sep 29 2016
    BioMarin to Cross $1 Billion Revenue in 2016 Sep 27 2016
    Higher Discontinuations Are among Orkambi’s Concerns Sep 26 2016
    How Ionis Pharmaceuticals’ Valuation Compares to Its Peers Sep 20 2016
    Sarepta Stock Surge Boosts Some Biotech ETFs But Not Others Sep 19 2016
    Inside the Recent Surge in Biotech ETFs Sep 14 2016
    Technicals, Politics Clash for Biotech ETFs Sep 06 2016
    How Is Incyte’s Only FDA-Approved Drug Performing? Sep 05 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)